Fatal hepatotoxicity associated with AMSA therapy.
D000609:Aminoacridines / Q000009:adverse effects* / Q000627:therapeutic use; D000677:Amsacrine; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006501:Hepatic Encephalopathy / Q000139:chemically induced; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008099:Liver / Q000187:drug effects*
D000609:Aminoacridines; D000970:Antineoplastic Agents; D000677:Amsacrine